Most people who start Wegovy notice their first side effects within one to three days of the injection, which tracks closely with how quickly the drug reaches its peak concentration in the bloodstream. Semaglutide, the active ingredient, takes roughly 30 to 56 hours to hit peak levels after a subcutaneous injection, and the gut-related symptoms that dominate early treatment tend to follow that same window. But the timing story gets more complicated as you move through the dose-escalation schedule, and some rarer effects operate on an entirely different clock.
Why the First Day or Two Matters
After you inject Wegovy into the skin of your abdomen, thigh, or upper arm, the semaglutide molecule absorbs slowly into your bloodstream. A systematic review of pharmacokinetic studies found that a single 0.25 mg dose reaches peak blood concentration at around 42 hours, while a 0.5 mg dose peaks closer to 56 hours. Once you have been taking weekly doses long enough to reach a steady state, that peak narrows to about 30 to 36 hours after each injection.1PubMed Central. Clinical Pharmacokinetics of Semaglutide: A Systematic Review – Section: Subcutaneous Route of Semaglutide In practical terms, this means the drug is at its strongest roughly a day and a half after you inject, and that is when most people feel the side effects most acutely.
The reason this matters is that semaglutide is not like a pill that spikes and fades within hours. It has a long half-life of about a week, which is what makes once-weekly dosing possible. But because the drug accumulates over several weeks, side effects do not always show up only on Day 1. Some people feel fine after their first injection and only notice symptoms after a few weeks, once steady-state levels are higher. Others feel nauseated within hours. The pharmacokinetic curve gives you a rough window, not a guarantee, of when you will personally feel effects.
The Gut Is Usually the First Thing You Notice
Nausea is far and away the most reported early side effect, and it tends to appear within the first 24 to 72 hours of a dose. Vomiting, diarrhea, and constipation round out the most common gastrointestinal complaints, and research consistently shows these are both transient and dose-dependent, meaning they are more likely to appear when the dose goes up and they tend to ease as your body adjusts.2Obesity Medicine. Adverse effects of GLP-1 receptor agonists: Clinical Implications, regulatory perspectives, and future directions – Section: Results
The mechanism behind the nausea is not mysterious. Semaglutide dramatically slows how fast your stomach empties after a meal. One study measured this directly using radiolabeled food and found that, four hours after eating, the semaglutide group still had about 37% of the solid meal sitting in their stomach, while the placebo group had emptied completely. The time for half the meal to leave the stomach jumped from about 118 minutes on placebo to 171 minutes on semaglutide.3PubMed. Semaglutide delays 4-hour gastric emptying in women with polycystic ovary syndrome and obesity – Section: RESULTS When food sits in your stomach longer than your brain expects, you feel full in a way that can tip into nausea, especially if you eat a large or fatty meal.
This is why one of the most effective strategies for managing early nausea is eating smaller meals and avoiding greasy or heavy food. The drug is literally slowing your digestive conveyor belt, so loading it up with a big dinner is a recipe for discomfort. Many people learn this intuitively within the first week or two, and the nausea often fades even without a dose change, simply because eating habits shift.
Each Dose Increase Resets the Clock
Wegovy’s prescribing schedule involves a gradual climb from 0.25 mg per week up to the full 2.4 mg maintenance dose, with increases every four weeks. This slow ramp-up exists specifically because side effects are dose-dependent. You may feel perfectly fine at 0.25 mg, develop mild nausea when you step up to 0.5 mg, feel it fade after two or three weeks, and then experience it all over again when you move to 1.0 mg. Each increase essentially restarts the adjustment period, though for most people each successive round is shorter and milder than the last.
The timing within each dose tier follows the same pharmacokinetic logic: your body needs a few weeks to reach steady state at the new dose, so side effects at a higher tier may actually be worst during weeks two and three of that tier, not week one. That catches some people off guard. They survive the first injection at a new dose and assume they are in the clear, then feel worse a couple of weeks later as the drug accumulates.
Skipping the escalation schedule or restarting at a high dose after a gap can cause serious problems. A published case report describes a 48-year-old woman who resumed semaglutide at 2 mg per week without following the recommended stepwise titration and developed persistent nausea and vomiting consistent with gastroparesis, a condition where the stomach essentially stops emptying on its own.4PubMed Central. Unmasking Semaglutide-Induced Gastroparesis: The Dangers of Rapid Dose Escalation in a Diabetic Patient If you miss several weeks and need to restart, your prescriber will typically have you step back down and re-escalate, precisely to avoid this kind of reaction.
Side Effects That Operate on a Longer Timeline
While nausea and digestive upset dominate the first days and weeks, a few less common side effects follow a different schedule entirely. These are not the ones most people experience, but they are worth knowing about because their timing is less intuitive.
Pancreatitis, an inflammation of the pancreas, has been linked to GLP-1 receptor agonists including semaglutide. It tends to surface weeks to months into treatment rather than days. One case report documented a young patient who developed acute pancreatitis five weeks after starting semaglutide, and cited a population-based study finding that people exposed to GLP-1 receptor agonists within the prior 30 days were roughly twice as likely to be hospitalized for pancreatitis compared to non-users.5PubMed Central. Acute Pancreatitis Likely Due to Semaglutide – Section: Discussion Symptoms include severe upper abdominal pain that radiates to the back, often with vomiting. The risk is small in absolute terms, but it is the kind of side effect that calls for immediate medical attention and stopping the medication.
Ocular side effects have also been flagged in real-world reporting data. A study analyzing adverse event reports found that most eye-related complaints occurred within the first month of starting injectable semaglutide, with a median time to onset of seven days. For the oral form, the median was even faster at about three and a half days.6PubMed Central. Association between various dosage forms of semaglutide and ocular adverse events in a real-world setting – Section: RESULTS These events are uncommon and range from blurred vision to more serious conditions. A small percentage of reports, roughly 5% for injectables, described eye-related events that appeared after a full year of treatment, so this is a side effect category that spans both the short and long term.
Why Side Effects Push People to Quit
Side effects are not just unpleasant; they are the leading reason people stop taking GLP-1 medications. A real-world study of over 1,300 patients found that nearly a third discontinued their GLP-1 therapy, and among those who quit, about 27% cited an adverse drug reaction as the reason. Cost concerns and non-adherence accounted for most of the rest.7Diabetes, Obesity and Metabolism. Characterisation of real-world patients who discontinued a glucagon-like peptide-1 agonist – Section: RESULTS
This means the question of when side effects start is tightly linked to whether people stick with the medication long enough for it to work. The dose-escalation period, which lasts about 16 to 20 weeks before you reach the full maintenance dose, is where the most turbulence happens. If you can get through that period, the odds of long-term tolerance improve considerably. But “getting through it” is easier to say than to live through, especially when you are dealing with daily nausea during the weeks after a dose increase.
Talking to your prescriber about managing side effects proactively, rather than waiting to see if they become unbearable, can make a real difference. Options include slowing the dose escalation by spending more time at each tier, adjusting meal timing around your injection day, or in some cases using anti-nausea medication during the adjustment window. The goal is to stay on the medication long enough for the gut to adapt, because for most people, it does.
Injection Day Timing and What It Means for Your Week
Because the drug peaks about a day and a half after injection, many people find it helpful to time their injection around their weekly schedule. Injecting on a Friday evening, for example, means the strongest effects hit over the weekend when you may be more able to rest and eat lightly. If you inject Monday morning, the nausea peak hits Tuesday afternoon, which could be less convenient if you have a demanding workday.
There is no single “right” day to inject, and the manufacturer does not specify one. The advice is simply to pick a day and stick with it each week, though you can shift the day if needed as long as there are at least two days between injections. Some people experiment during the first month to find a day that works with their routines. The key insight is that semaglutide is not an immediate-onset drug, so the injection itself is painless for most people. The side effects show up later, and knowing roughly when gives you the ability to plan around them.
How Wegovy’s Side Effect Profile Compares to Newer Options
If you have heard of tirzepatide (sold as Mounjaro for diabetes and Zepbound for weight loss), you may wonder whether it causes similar side effects on a similar timeline. The short answer is yes, the gastrointestinal side effects are broadly similar in type and onset, because tirzepatide also activates GLP-1 receptors and slows gastric emptying. Research has noted that tirzepatide consistently produces greater weight loss than semaglutide, likely because it hits two receptors instead of one, but with that extra potency comes a similar or sometimes slightly higher rate of gut-related complaints during dose escalation.8PubMed Central. A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Efficacy and Adverse Events
The timing is comparable because the underlying mechanism, slowed stomach emptying triggered by GLP-1 receptor activation, is shared. Tirzepatide also uses a gradual dose-escalation schedule for the same reason Wegovy does: jumping to a high dose without letting the body adjust leads to worse side effects. So if you switch from one to the other, expect a similar adjustment curve, though individual responses vary enough that some people tolerate one noticeably better than the other.
When Side Effects Are Not Just Side Effects
Most side effects from Wegovy are genuinely harmless, if unpleasant, and they do tend to resolve. But a few warrant a call to your doctor rather than a wait-and-see approach. Severe abdominal pain that does not pass, especially if it radiates to your back, could indicate pancreatitis. Persistent vomiting that lasts for days and prevents you from keeping fluids down is a sign that the dose may be too high or that gastric emptying has slowed to a dangerous degree. Significant vision changes in the first weeks or months should not be dismissed as unrelated.
There is also a subtler category of effects that are easy to misattribute. Fatigue, headaches, and general malaise during the first weeks can be caused partly by the medication and partly by the sudden drop in calorie intake that accompanies the appetite suppression. If you are eating significantly less than before, your body needs time to adjust to that, independent of the drug’s direct pharmacological effects. Making sure you are eating enough protein and staying hydrated, even when your appetite is suppressed, helps distinguish drug side effects from simple under-eating.
Injection Site Reactions and How Quickly They Appear
Unlike the systemic side effects that follow the pharmacokinetic peak, injection site reactions are essentially immediate. Redness, mild swelling, or itching at the injection spot can appear within minutes to hours. These are localized responses to the needle and the injected solution rather than to semaglutide circulating through your system, so they follow a completely different timeline. They also tend to be mild and short-lived, resolving within a day or two. Rotating injection sites between your abdomen, thigh, and upper arm helps minimize them.
A small number of people develop more persistent redness or nodules at injection sites, which can last a week or more. This is not dangerous but can be annoying, and it is worth mentioning to your prescriber if it happens repeatedly. In rare cases, true allergic reactions at the injection site, with significant swelling, hives, or breathing difficulty, require emergency attention. These are distinct from the common minor reactions and are uncommon enough that they should not deter someone from starting the medication, but recognizing the difference matters.